Tecan takes annual scientific symposium to Shanghai
Publication date: 6 October 2011
Author: kdm communications
Tagged with: Tecan
Tecan is a leading global provider of advanced laboratory automation solutions across a wide range of sectors and, to reflect the Company’s international position, this year’s Tecan Symposium will be held in Shanghai, China, from the 2nd to 4th of November.
Now in its fourth year, the popular Tecan Symposium brings together prominent scientists from a broad spectrum of scientific backgrounds, combining a unique scientific symposium with a relaxed environment to discuss the latest trends and developments in life sciences.
The topic of this year’s symposium is ‘Translational Medicine: From bench to bedside and back’, and will cover a wide range of scientific topics in this rapidly expanding area of research. Divided into translational medicine and biobanking sessions, the symposium will feature a number of high profile speakers – including CEO of the Coriell Institute, Dr Michael Christman, Director of Translational Research Informatics at Kyoto University, Dr Masanori Fukushima, and Dr Huanming Yang, President of the Beijing Genomics Institute. Alongside the main presentations, the Tecan Symposium provides guests with an open forum to discuss the latest technological innovations and current issues in research, providing an unparalleled opportunity to advance our understanding of the world around us while enjoying Tecan’s hospitality.
To find out more about the Tecan Symposium, including details regarding free registration, visit www.tecan.com/symposium2011
Advertisement:
Email newsletter
If you enjoyed this article sign-up to receive our bi-weekly email newsletter:
Latest news
- Fast plasma sample cleanup with new Phree Phospholipid Removal Plates (21 May 2012)
- Two overall winners announced at prestigious national award ceremony in London’s Science Museum (18 May 2012)
- New analysis of risk stratification for TYSABRI® published in New England Journal of Medicine (18 May 2012)
- NUCYNTA® ER (tapentadol) tablets provide pain management for patients with Diabetic Peripheral Neuropathy (DPN) (18 May 2012)
- GSK statement on tender offer to acquire Human Genome Sciences (18 May 2012)
In-depth focus:
Mass Spectrometry
This free to view Mass Spectrometry in-depth focus is sponsored by Waters, Bruker, Protea and Dr. Hochmuth and contains the following articles:
- Mass spectrometry in drug discovery - Proteomics, small molecules and metablomics
- Quantification of membrane drug transporters and application in drug discovery and development
- Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
Company directory
ABB Analytical Measurements | Almac | B&W Tek, Inc. | BASF | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Optics | CAMO Software AS | Catalent Pharma Solutions | Chemspec Europe Ltd | CI Precision | Cisbio Bioassays | EMD Millipore | GE Analytical Instruments | Gerresheimer Group | HACH LANGE GMBH | HORIBA Scientific | I Holland Limited | Lonza | Merck Millipore | Pall Life Sciences | Patheon Inc | Phenomenex | Porvair Sciences Ltd | Randox Pharma Services | Rapid Micro Biosystems | Realia | Roche | rommelag® | Umetrics |
Login to access exclusive content